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separated by 22 bp instead of 17 bp (see Figure S1, available as
Supplementary data at JAC Online). An additional promoter was
predicted by Softberry BPROM promoter prediction and consisted
of the 235 box of IS18 and a 210 box separated by 13 bp
(Figure S1, available as Supplementary data at JACOnline).10 Inter-
estingly, the TTCAAT235 box identical to that from Baz (blaOXA-228)
was adjacent to the left inverted repeat.
OXA-228-like expression in isolate KH243 was compared with
that in carbapenem-susceptible A. bereziniae isolate G3-59 by
semi-quantitative RT–PCR (qRT–PCR) using rpoB as the reference
gene. The primers used for qRT–PCR are shown in Table 1. Three
independent experiments were performed using freshly prepared
RNA and cDNA and revealed a 56-fold (+3.84) overexpression of
blaOXA-228-like in isolate KH243 compared with that in G3-59. To
investigate the potential to mediate carbapenem resistance,
IS18::blaOXA-257 was cloned into the shuttle vector pWH1266,
but we were unable to transfer this into A. bereziniae G3-59.
However, the construct was successfully transferred into
A.baumanniiATCC17978byelectroporation,aspreviouslydescribed
for Pseudomonas aeruginosa.11 Expression of blaOXA-257 in
A. baumannii ATCC 17978 raised both imipenem and meropenem
MICs from 0.25 to .32 mg/L, demonstrating that IS18::blaOXA-257
is able to confer carbapenem resistance.
In conclusion, this study has detected an IS upstream of the
intrinsic blaOXA in A. bereziniae, a phenomenon that has not been
described in this species so far. IS18 conferred overexpression of
OXA-257, which mediated carbapenem resistance in A. bereziniae
and A. baumannii. Moreover, because IS18 has previously been
described adjacent to acquired blaOXA in A. baumannii,
8 these
data suggest a potential for dissemination of OXA-257 in the
genus Acinetobacter.
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Sir,
A multiresistant CTX-M-15-producing clonal group of Escherichia
coli isolates belonging to phylogroup B2, namely O25b:H4/
ST131, has recently emerged and spread across three conti-
nents; it predominantly causes community-onset infections in
humans and to a lesser extent in dogs and cats.1 – 3 Some specif-
ic lineage variations within this clone, detected by PFGE, such as
pulsotype 968, have been associated with clonal commonality
across pets and humans.4,5 Important comparative studies to
date have only included a small number of isolates from com-
panion animals.
A total of 148 ST131 isolates, identified by screening unselected
sequential isolates, were compiled in two different studies carried
out in Lisbon (n¼59) and Seville (n¼89). The veterinary E. coli iso-
lates (n¼31) were collected during 2004–09 from dogs and cats
with a urinary tract infection (UTI). Portuguese human UTI clinical
isolates (n¼28) were obtained during 2005–06 in one hospital
and in a community diagnostic laboratory covering an area of
365000 inhabitants in the Lisbon region. ST131 human isolates
from Seville were collected from a systematic prospective study in
which all E. coli isolates from two hospitals covering an area with
1 million inhabitants were screened for O25b serogroup during
30 weeks in 2010. Isolates from Seville were mainly recovered
from UTI (98%).6
The ST131 clone was screened by PCR with specific primers for
O25b rfb, allele 3 of the pabB gene and B2 genetic traits, and by
multiplex PCR for phylogroup B2 typing using two different combina-
tions of primers.7,8 Susceptibility testing was performed using com-
mercial microdilution plates and the disc diffusion method for
nalidixic acid, ciprofloxacin, amoxicillin/clavulanic acid, gentamicin,
tobramycin, amikacin, trimethoprim/sulfamethoxazole and fosfo-
mycin. Extended-spectrum b-lactamase (ESBL) production was
screened for by the double-disc synergy test, and ESBL typing
was determined by PCR and further sequencing.2 PFGE analysis
was carried out accordingto the PulseNet protocol in both laborator-
ies. Salmonella serotype Braenderup strain H9812 was used for
normalization and dendrograms were created with Fingerprinting
3.0 software (Bio-Rad), using the Dice coefficient.
In this collection of ST131 isolates from the B2 phylogenetic
group, the overall prevalence of ESBL producers was 41% (n¼60).
Fifty-six (93%) harboured CTX-M-15, three (5%) CTX-M-32 and one
(2%) CTX-M-14. Higher rates of ESBL production were observed in
the human-derived isolates than in the pet-derived isolates: 57
ESBL-producing human isolates out of 117 (49%) versus three ESBL-
producing animal isolates out of 31 (10%). Human ST131
isolates were found to be more resistant to ciprofloxacin, trimetho-
prim/sulfamethoxazole and tobramycin than isolates from pets
(P,0.001). With respect to the ESBL-producing isolates examined
Figure 1. Dendogram showing the six ST131 E. coli clusters based on the XbaI-generated profile (Dice similarity value≥94%, black line), which included
pulsotypes common between Spain and Portugal, common between human and pets, and matching with international pulsotypes. Grey squares, positive
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in this study, most harboured CTX-M-15, as was universally observed
in previous surveys of humans and companion animals.1,5,9 Fosfo-
mycin resistance was higher in Portugal than in Seville among
human-derived isolates (P,0.001) and, in contrast with previous
reports from Spain,10 this resistance trait has arisen independently
in different human pulsotypes.
A total of 95 pulsotypes were distinguished (see Figure S1, avail-
able as Supplementary data at JAC Online). Three clusters (7% of
human isolates) included isolates from Seville and Lisbon. Only
one cluster containing one human and one dog isolate was
detected. Seven (6%) human isolates exhibited a close genetic re-
lationship with international PFGE profiles: four isolates from Seville
matched type 903, and a cluster containing three human isolates
from Lisbon and one from Seville matched type 968 (Figure 1). An
additional Spanish isolate showed a similar profile to pulsotype
800. Isolates clustering with pulsotype 968 were all resistant to
ciprofloxacin, three out of four were intermediately resistant or
resistant to fosfomycin and one was a CTX-M-15 producer.
This studyconfirmed that some predominant lineages within the
ST131 clone, mainly pulsotype 968, are present and have spread in
Portugal and Spain. However, common patterns between these two
countries accounted for less than 10% of all isolates, probably
because of the different time frame of the collections from Portugal
(2004–09) and Spain (2010). This is the first report of pulsotype
968 in Spain. The 968 pulsotype had been previously detected
among human ST131 isolates in Portugal.4,11 In our survey, this
transboundary968typewas exclusivelyobservedamonghumanin-
fection isolates, in contrast with previous studies where it was asso-
ciated with pets.4,11The 968 type belongs to the fimH30 type, which
was significantly associated with fluoroquinolone resistance.12
Only 3%of the Portuguese group contained pulsotypesthat were
common between humans and pets. Our results agreewiththe con-
clusionsofa large international comparisonof isolates carried outby
Johnson et al.,4 which argued against pet–human commonality for
ST131 isolates. None of the animal isolates could be associated with
the prevalent pulsotypes. Isolates from companion animals were
also less clustered and represented single pulsotypes, which may
suggest less dissemination among pets.
The present work demonstrates the presence of high-prevalence
international pulsotypes in two different countries in the south of
Europe. However, the study has some limitations, in terms of the
small number of cases in some groups and the differences in time
frame between the areas. Nonetheless, variability among E. coli
ST131 isolates at the pulsotype level was country-specific with
little exchange between Seville and Lisbon and between humans
and companion animals. In this study, the E. coli ST131 within-
lineage genetic variation that was found argues in favour of a
rapid host species adaptation and an ongoing dissemination of
this antimicrobial drug-resistant pathogen.
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